Private Advisor Group’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Private Advisor Group’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-31	Closed	-$12K	–	1481
2017 Q1	$12K	Buy	+31	New	+$13.4K	﹤0.01%	1401

Other funds holding NURO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Private Advisor Group's NURO Position: Q2 2017 in Review

Private Advisor Group sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2017, closing a stake of 31 shares — an estimated $12K sold.

Private Advisor Group first reported a position in NURO in Q1 2017 and held it in 1 quarter. The position peaked at $12K in Q1 2017. 7 funds tracked by Wall St. Rank hold NURO as of Q2 2017.

Private Advisor Group reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Private Advisor Group sold 31 NeuroMetrix, Inc. Common Stock shares in Q2 2017, an estimated $12K.
Private Advisor Group first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
Private Advisor Group's NeuroMetrix, Inc. Common Stock position peaked at $12K in Q1 2017.
7 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2017.

Based on Private Advisor Group's 13F filing for Q2 2017, filed 10 Aug 2017.